Arphra/Issuer/AVTR

AVTR

Avantor, Inc.

HealthcareMedical - Instruments & SuppliesUSUSD

$9.19

LiveJun 01, 2026

AI Brief

Market cap

$6.27B

52w range

7.26 – 15.93

P / E

—

EPS

—

Volume

12.88M

Revenue · FY

$6.55B

-3.41% YoY

Explain this page

Arphra AIPlain-English read on Avantor, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for AVTR.

Peers

No peer list available for AVTR.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+0.77%	+11.26%	+15.45%	+1.55%	-21.79%	-19.81%	-29.09%	-53.82%	-70.69%	-36.62%	-36.62%

Aftermarket

Live

Jun 01, 08:25 PM

Last trade

$9.02

12,491 sh

Bid

$8.89

100 sh

Ask

$9.05

6 sh

Spread

$0.160

Sector & industry today

Live

Sectors

Technology
+3.30%
Basic Materials
+0.98%
Energy
+0.83%
Consumer Cyclical
+0.49%
Industrials
+0.25%
Communication Services
+0.13%
Healthcare
-0.65%
Financial Services
-0.80%
Consumer Defensive
-0.84%
Utilities
-1.15%
Real Estate
-1.32%

Top industries (issuer's industry highlighted)

Medical - Instruments & Supplies
-0.93%
Computer Hardware
+8.35%
Software - Infrastructure
+7.61%
Consulting Services
+5.28%
Coal
+5.20%
Manufacturing - Metal Fabrication
+4.24%
Staffing & Employment Services
+4.08%
Gambling, Resorts & Casinos
+3.71%
Broadcasting
+3.70%
Integrated Freight & Logistics
+3.68%
REIT - Healthcare Facilities
-3.49%
Software - Application
+3.44%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $9.44 (+2.72%)

Total assets

$11.79B

Total debt

$3.95B

Cash & equiv

$365.4M

Operating CF

$623.8M

Free cash flow

$495M

Buybacks

-$80.7M

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for AVTR.

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$1.58B	$43.3M	$0.06
Q4 Dec 2025	$1.66B	$52.4M	$0.08
Q3 Sep 2025	$1.62B	-$711.8M	$-1.04
Q2 Jun 2025	$1.68B	$64.7M	$0.09
Q1 Mar 2025	$1.58B	$64.5M	$0.09
Q4 Dec 2024	$1.69B	$500.4M	$0.73

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$6.55B	-$246.2M	-$530.2M	$-0.78	-8.09%
FY 2024	$6.78B	$1.08B	$711.5M	$1.04	+10.49%
FY 2023	$6.97B	$696.4M	$321.1M	$0.47	+4.61%
FY 2022	$7.51B	$1.13B	$686.5M	$1.01	+9.14%
FY 2021	$7.39B	$972.2M	$572.6M	$0.85	+7.75%